Dermapharm Holding SE: AGM Approves €0.88 Dividend Per Share

• Annual General Meeting resolves dividend distribution of EUR 0.88 per share.
• 2024 outlook confirmed with expected consolidated revenue of EUR 1,170–1,210 million and adjusted consolidated EBITDA of EUR 305–315 million.
• Board of Management and Supervisory Board actions ratified with large majority (98.6% and 91.5% respectively).
• 90.3% of share capital attended the meeting, approving all management's proposals.
• Grant Thornton AG re-elected as auditor; RSM Ebner Stolz GmbH & Co. KG chosen for sustainability reporting.
• Dermapharm emphasizes strength and resilience in 2023, with significant investments in internationalization and sustainability.

The next important date, Dermapharm Holding SE - Annual General Meeting, at Dermapharm Holding is on 27.06.2024.

The price of Dermapharm Holding at the time of the news was 36,48EUR and was up +0,83 % compared with the previous day.
At this time, the index SDAX was at 14.362,57PKT (+0,40 %).

Dermapharm Holding

-2,07 %

-5,87 %

-8,04 %

-10,99 %

+12,83 %

-39,56 %

+0,32 %

+20,10 %

ISIN:DE000A2GS5D8WKN:A2GS5D

• Intraday
• 5 Tage
• 1 Monat
• 3M
• 1 Jahr
• 3J
• 5J
• Max